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Murine Caspase-11, an ICE-Interacting Protease,
Is Essential for the Activation of ICE
normally, but they are resistant to endotoxic shock in-
duced by lipopolysaccharide (LPS), which can be attrib-
uted to their defect in the production of mature IL-1 and
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Recently, we demonstrated that a mutant ICE in whichBiomedical Research Center
the active site cysteine has been changed into a glycineOsaka University Medical School
is a powerful inhibitor of apoptosis under pathological2±2 Yamadaoka
conditions (Friedlander et al., 1997a, 1997b). Interest-Suita, Osaka 565-0871
ingly, transgenic mice expressing this mutant ICE areJapan
developmentally normal but resistant to apoptosis in-
duced by middle cerebral artery occlusion, a mouse
model of stroke (Friedlander et al., 1997a). In addition,
expression of this mutant ICE in neurons of mutant SODSummary
mice, a mouse model of human aymotrophic lateral scle-
rosis, is able toslow thesymptomatic progression of thisWe report here the inactivation of a member of the Ice/
disease and delay mortality (Friedlander et al., 1997b).Ced-3 (caspase) family of cell death genes, casp-11, by
Since ICE has been shown to be an important regulatorgene targeting. Like Ice-deficient mice, casp-11 mu-
of inflammatory response, the experiments suggest thattant mice are resistant to endotoxic shock induced
inflammation may be a major cause of cell death inby lipopolysaccharide. Production of both IL-1a and
diseases, and specific inhibition of the ICE pathway mayIL-1b after lipopolysaccharide stimulation, a crucial
offer protection against diseases without altering devel-event during septic shock and an indication of ICE
opment. In other words, the ICE pathway may be anactivation, is blocked in casp-11 mutant mice. casp-11
ideal therapeutic target for certain diseases.mutant embryonic fibroblast cells are resistant to
Murine caspase-11, originally named Ich-3, is a mem-apoptosis induced by overexpression of ICE. Further-
ber of the ICE subfamily of proteases and is most homol-more, we found that pro-caspase-11 physically inter-
ogous to human caspase-4 (Wang et al., 1996). Like Ice,acts with pro-ICE in cells, and the expression of casp-
overexpression of casp-11 induces apoptosis in Rat-111 is essential for activation of ICE. Our data suggest
fibroblasts, and casp-11-induced cell death could bethat caspase-11 is a component of ICE complex and
prevented by bcl-2 and crmA. Differing from Ice, how-is required for the activation of ICE.
ever, expression of casp-11 is highly inducible by LPS,
suggesting that casp-11 may have a regulatory role in
Introduction both apoptosis and inflammatory responses. Caspase-
11 does not process pro-IL-1b directly, but overexpres-
The mammalian caspase family of cysteine proteases sion of casp-11 stimulates processing of pro-IL-1b by
are homologs of C. elegans cell death gene ced-3 and ICE (Wang et al., 1996). To understand the mechanism
have been shown to play important roles in regulation of caspase-11 action, we generated casp-11 mutant
of apoptosis and inflammatory responses. Interleukin- mice by gene targeting technique. We found that casp-
1b-converting enzyme (ICE), the first member of the 11-deficient mice are resistant to a lethal dose of LPS,
mammalian caspase family, is the only caspase identi- which can be attributed to a lack of mature IL-1 produc-
fied so far that can process pro-interleukin-1b (pro-IL- tion. casp-11-deficient cells are resistant to apoptosis
1b) into mature IL-1b (Cerretti et al., 1992; Thornberry induced by ICE, indicating that activation of ICE requires
et al., 1992) and interferon-g-inducing factor (IGIF/IL- caspase-11. Furthermore, pro-caspase-11physically in-
18) efficiently in vitro (Ghayur et al., 1997; Gu et al., 1997) teracts with pro-ICE in cells. Our results suggest that
and in vivo (Kuida et al., 1995; Li et al., 1995). ICE is casp-11 encodes a component of ICE complex and is
synthesized as a precursor of 45 kDa, which is proteolyti- required for ICE activation.
cally cleaved during activation to generate two subunits
of 22 kDa (p20) and 10 kDa (p10) (Thornberry et al., 1992). Results
X-ray crystallography analysis of the three-dimensional
Generation of a Null Mutation in thestructure of ICE showed that mature ICE is a tetramer
casp-11 Gene in Miceof two p20 and two p10 subunits (Walker et al., 1994;
To obtain the genomic clone of the casp-11 locus, weWilson et al., 1994). Mice that are deficient in Ice develop
screened a mouse 129/Sv genomic library using casp-
11 cDNA as a probe (Wang et al., 1996). casp-11 is a
single-copy gene consisting of at least eight exons (Fig-§To whom correspondence should be addressed.
| These authors contributed equally to this work. ure 1). Exon 1 only encodes three amino acids, including
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Figure 1. Targeted Disruption of the casp-11 Gene
Structure of the mouse casp-11 gene. The exons are depicted as open boxes and numbered from the exon encoding ATG translation initiation
codon. Amino acid residues of each exon are indicated in the parentheses. The locations and transcription orientation of PGKneo and HSVtk
selection cassettes are indicated. Restriction enzyme sites used for construction and Southern blotting are shown. Diagnostic probes used
for Southern blot analysis are shown on the top of the figure (probe A).
the initiation codon ATG for Met. The active site penta- mutant casp-11 allele is close to Mendelian ratio. The
litter size from homozygous casp-11-deficient male andpeptide QACRG is encoded in exon 5. A replacement-
type targeting vector was constructed for selecting ho- female mice mating was the same as heterozygous
crosses with a 1 to 1 male and female ratio (data notmologous recombination events in the casp-11 locus
(Figure 1). In this construct, a 1.5 kb casp-11 genomic shown). These results suggest that mutation in thecasp-
11 locus does not cause any gross abnormalities inDNA fragment containing the coding region for the ac-
tive site QACRG pentapeptide was replaced with the general health and reproduction of mice.
neo gene encoding neomycin phosphotransferase. This
insertion/substitution resulted in deletion of 16 amino casp-11 Mutant Mice Do Not Express Wild-Type
Caspase-11 Protein but Express a Normalacids from the coding region of casp-11 in exon 5, in-
cluding the QACRG active site. Amount of ICE
A monoclonal antibody was generated against caspase-Mutant ES cell clones were generated as described
in Experimental Procedures. Three clones (clones 282, 11 (Wang et al., 1996). This caspase-11 antibody recog-
nizes two proteins of 43 and 38 kDa in LPS-stimulated444, and 531) were expanded for injection of C57BL/6J
blastocysts. All three clones gave rise to highly chimeric tissue (Wang et al., 1996). To determine if these two
proteins are encoded by the casp-11 locus and whethermales that were then mated with C57BL/6J 3 DBA2 F1
females to obtain germline transmission of the mutant the mutation has eliminated both products, we isolated
proteins from spleen tissues of wild-type and casp-11alleles. Chimera of clone 444 produced germline trans-
mitted mutant mice, and the offspring from clone 444 mutant mice before and after LPS injection. Western
blots probed with this antibody showed that these twochimera were used for further studies. As expected,
about 50% of the offspring with agouti coat color that proteins are induced by LPS and completely absent in
casp-11 mutant mice (Figure 2). Thus, the casp-11 locusderived from mating chimeras with C57BL/6J mice were
heterozygous as determined by Southern blot analysis. encodes two proteins of 43 and 38 kDa. Since the tar-
geted mutation in casp-11 has eliminated expression ofHeterozygous mice were crossed, and the genotypes
were determined by Southern blot (see Experimental both proteins, we have created a null allele of casp-11.
To test if a deficiency in casp-11 affects the expres-Procedures). Of the progeny from such crosses, 30%
of the mice were homozygous for the mutant allele, sion of Ice, we analyzed the expression of Ice by Western
blot using a monoclonal antibody raised against a p2023% were wild type, and 47% were heterozygous as
determined by Southern blot analysis of tail DNA (total subunit of ICE that recognizes p45 ICE protein specifi-
cally (data not shown). We could see a comparablenumber of mice tested: 661). Thus, segregation of the
Interaction of ICE and Caspase-11
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Figure 2. casp-11 Mutant Mice Do Not Express Caspase-11 Protein
but Express a Normal Amount of ICE
Proteins were isolated from spleen tissues of both wild-type (1/1)
and casp-11 (2/2) mutant mice without LPS injection or 4 hr after
LPS injection at a dose of 40 mg/kg body weight. Thirty micrograms
of proteins were loaded in each lane for Western blot analysis using
anti-ICE p20 monoclonal antibody and anti-caspase-11 monoclonal
antibody.
Figure 3. Survival of casp-11-Deficient Mice after Administration
with Lethal Dose of LPS
amount of Ice expression in the spleens of wild-type
Survival of casp-11-deficient (2/2), heterozygous (1/2), and wild-
and casp-112/2 mice before and after LPS injection (Fig- type (1/1) mice after injection of a lethal dose of LPS (40 mg LPS/
ure 2). Thus, the absence of the casp-11 gene product kg body weight) were tested. A total of ten casp-11 mutant (five
males, five females), nine heterozygous (eight males, one female),does not have any obviousadverse effect on the expres-
and nine wild-type (three males and six females) were tested in atsion of Ice.
least three independent experiments.
casp-11-Deficient Mice Develop Normally
mice survived 4 days after receiving LPS (Figure 3).
The casp-11-deficient mice develop normally, and their
Similar symptoms of endotoxic shock were observed in
growth rate is the same as wild type in postnatal devel-
casp-11-deficient mice, but they were less lethargic and
opment (data not shown). Histological analysis of kid-
most of them recovered within 48 hr. Most of the casp-
ney, thymus, heart, and lung, in which casp-11 expres-
11-deficient mice (80%) survived 4 days after LPS treat-
sion is higher than other tissues, from 7±10 week-old
ment. Survival rate of heterozygous mice was about half
mice showed no gross abnormalities (data not shown).
that of the casp-11-deficient mice (44%).
We examined the percentages of different subsets of T To investigate whether casp-11 mutant mice have a
cells from freshly isolated thymocytes by flow cytome- defect in production of proinflammatory cytokines in
try. There is no significant difference in the distribution vivo, which may explain why they are resistant to LPS,
of CD41CD81, CD41CD82, CD42CD81, or CD42CD82 we examined the plasma levels of IL-1a and IL-1b, which
populations as compared with those of wild-type mice are dramatically reduced in Ice-deficient mice (Kuida et
(data not shown). al., 1995; Li et al., 1995). LPS at a dose of 40 mg/kg of
body weight was administrated to casp-11 mutant and
wild-type mice, and plasma levels of IL-1a and IL-1b
casp-11-Deficient Mice Are Resistant were measured by ELISA before and 5 hr after LPS
to Septic Shock injection. IL-1a and IL-1b were undetectable in both
Administration of LPS to mice induces production and mutant and wild-type mice under control conditions.
secretion, largely by macrophages and monocytes, of Plasma IL-1b levels were significantly increased in wild-
proinflammatory cytokines that are subsequently re- type mice 5 hr after LPS injection. Interestingly, plasma
leased into circulation (Dinarello et al., 1993). Intraperito- IL-1b levels in casp-11 mutants are undetectable 5 hr
neal injections of a high dose of LPS in mice induces after LPS injection (Table 1), suggesting that casp-11
lethal endotoxic shock. Wild-type mice show a series has a regulatory role in mature IL-1b production in vivo.
of responses such as shivering, fever, lethargy, watery Plasma levels of IL-1a are also significantly lower in Ice-
eyes, and, ultimately, death. Ice-deficient mice are resis- deficient mice than in wild-type mice after LPS stimula-
tant to lethal doses of endotoxin presumably because tion (Kuida et al., 1995; Li et al., 1995), suggesting that
of a dramatic reduction in release of proinflammatory ICE may have an indirect role in regulating IL-1a produc-
cytokines such as IL-1a, IL-1b, and IGIF (Kuida et al., tion and secretion. Thus, we examined if casp-11 mutant
1995; Li et al., 1995; Ghayur et al., 1997; Gu et al., 1997). mice have a defect in IL-1a production. We found that
To examine if casp-11-deficient mice are also resistant casp-11-deficient mice also have severely reduced
to LPS, 8-week-old wild-type and casp-11-deficient plasma levels of IL-1a after LPS stimulation (Table 1).
mice were injected intraperitoneally with LPS at a dose Thus, like Ice2/2 mice, processing and secretion of IL-
1b and IL-1a stimulated by LPS are both blocked inof 40 mg/kg body weight. Only 11% of the wild-type
Cell
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Table 1. Plasma Cytokine Levels in Endotoxic Shock
Cytokine Concentration
(pg/ml)
Cytokine Stimulus casp-111/1 casp-112/2
IL-1a LPS 850 6 150 40 6 24
IL-1b None 0* 0*
LPS 195 6 60 0*
casp-11 mutant (2/2) and wild-type (1/1) mice were bled from the
retro-orbital plexus 5 hr after LPS stimulation. The plasma was used
for ELISA. The data are mean 6 SEM of at least three individual
mice. *: lower than detection level.
casp-112/2 mice. Since processing of pro-IL-1b is a spe-
cific indication of ICE activation, these data suggest
that, in the absence of caspase-11, LPS-stimulated ICE
activation cannot occur.
ICE-Induced Apoptosis Requires Caspase-11
We used Ice overexpression±induced apoptosis as an
assay to determine if activation of ICE requires caspase-
11. Transient transfection of an Ice expression construct
has been shown to induce apoptosis of tissue culture
cells very efficiently (Miura et al., 1993). To determine if
overexpression of ICE±induced apoptosis requires cas-
pase-11, we cotransfected immortalized casp-112/2
embryonic fibroblasts (EF) with an expression construct
of Ice or an expression construct of casp-11 and a GFP
expression construct in a 10 to 1 ratio. Transfected cells
Figure 4. ICE-Induced Apoptosis Requires Caspase-11were identified by their green fluorescence under UV
(A) casp-112/2 immortalized EF cells were transfected with Iceillumination 12 hr after transfection. Apoptotic cells are
(pM10Z) or casp-11 (pM26Z) expression constructs together withround with membrane blebbing when examined with
green fluorescence protein expression vector EGF as an indicator.phase contrast microscopy. Transfection of immortal-
The percentages of apoptotic cells were determined 12 hr after
ized casp-11 mutant EF cells with casp-11 induced cell removal of transfection media by fluorescence and phase contrast
death in 39% of the cells, while expression of Ice caused microscopy. The percentage of apoptotic cells was estimated from
only 17% of the cells to die, which is close to control the numbers of green fluorescent round cells with membrane bleb-
bing to that of flat healthy cells. Data were from three independentfor GFP-transfected cells (14% cell death) (Figure 4A).
experiments.Ice and casp-11 expression constructs are equally effi-
(B) Caspase-11-induced apoptosis does not require ICE. Ice2/2 im-cient in inducing wild-type EFcells to undergo apoptosis
mortalized EF cells were transfected with Ice and casp-11 expres-
(data not shown). These results suggest that ICE- sion constructs and percentages of apoptotic cells were determined
induced apoptosis requires caspase-11. as in (A).
To determine if overexpression of casp-11±induced (C) Pro-ICE processing in cells requires caspase-11 activity. An
Ice expression construct (pS34) was transfected into wild-type andapoptosis requires ICE, we did the reciprocal experi-
casp-11 mutant immortalized EF cells, and the cells were collectedment. We cotransfected immortalized Ice2/2 EF with an
16 hr after the transfection. The processing of ICE was detectedexpression construct of Ice or an expression construct
by Western blotting using a monoclonal antibody against the p20
of casp-11 and a GFP expression construct as a 10 to subunit of ICE.
1 ratio. The percentages of apoptosis were determined
as described above. Both ICE and caspase-11 induced
apoptosis efficiently in Ice2/2 cells. Thus, although ICE-
proportional to the amount of pro-ICE expressed; ininduced apoptosis requires caspase-11, caspase-11-
casp-112/2 EF cells, significantly less processed ICE isinduced apoptosis does not require ICE.
detected than that in wild-type cells when transfectedNext we examined the possibility that caspase-11 is
with 1 mg of pro-ICE expression construct, and no pro-required for the activation of ICE by determining the
cessed ICE can be detected when 0.5 mg of pro-ICEprocessing of pro-ICE in Ice-transfected wild-type and
expression construct is transfected in casp-112/2 cellscasp-112/2 cells by Western blotting. Wild-type and
(Figure 4C). Thus, our data suggests that activation ofcasp-112/2 immortalized EF were transfected with a
ICE requires caspase-11.Flag-tagged Ice expression construct. The cells were
collected 16 hr after transfection, and processing of pro-
ICE was determined by Western Blotusing a monoclonal Caspase-11 and ICE Physically Interact in Cells
Since our data from casp-11 mutant mice indicate thatantibody against the p20 subunit of ICE, which recog-
nizes pro-ICE as well as the processed p20 subunit caspase-11 is required for activation of ICE in vivo, we
tested the possibility that pro-caspase-11 can form aof ICE. In wild-type EF cells, processing of pro-ICE is
Interaction of ICE and Caspase-11
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Thus, our result indicates that endogenous pro-cas-
pase-11 and pro-ICE physically interact in cells.
Discussion
The critical role of caspase-11 in the ICE pathway is
underlined by the ability of casp-112/2 mutant mice to
resist LPS-induced lethality. LPS is a potent inducer of
mature IL-1 processing and the secretion of lympho-
kines necessary for the septic shock response (Arend
and Massoni, 1986; Newton, 1986). ICE is the only cas-
pase directly involved in pro-IL-1b processing in vitro
and in vivo (Thornberry et al., 1992; Kuida et al., 1995;
Li et al., 1995). While a critical role of ICE in processing
of pro-IL-1b is clear, the mechanism of pro-ICE activa-
tion is far from understood. Four lines of evidence sup-
port our hypothesis that caspase-11 plays a critical role
in ICE activation. First, although caspase-11 does not
directly process pro-IL-1b, cotransfection of caspase-
11 with Ice stimulated the ability of ICE to process pro-
IL-1b (Wang et al., 1996). Second, LPS-stimulated acti-
vation of ICE, as indicated by the secretion of mature
IL-1b, does not occur in the absence of caspase-11 in
vivo. Third, ICE does not induce apoptosis in the ab-
sence of caspase-11. Fourth, pro-ICE cannot be acti-
vated in the absence of caspase-11. The caspase family
Figure 5. Caspase-11 Physically Interacts with ICE in Cells now consists of twelve mammalian members (Fernan-
(A) Overexpressed casp-11(pS26) and Ice (pM17-T7) physically in- des-Alnemri et al., 1994, 1995a, 1995b, 1996; Kumar et
teract with eachother. COS cells were transfectedwith the indicated al., 1994; Wang et al., 1994; Faucheu et al., 1995; Kamens
expression vectors. Cell lysates were immunoprecipitated with the et al., 1995; Munday et al., 1995; Tewari et al., 1995;
indicated polyclonal antibodies (IP Ab: immunoprecipitation anti-
Boldin et al., 1996; Duan et al., 1996a, 1996b; Lippke etbody). Coprecipitating proteins were analyzed by immunoblotting
al., 1996; Muzio et al., 1996; Shi et al., 1996; Van dewith monoclonal antibodies as indicated (WB Ab: Western blot an-
Craen et al., 1997). Physical interaction between differ-tibody).
(B) Endogenous ICE and caspase-11 interact. L929 cell lysates were ent caspases may not be limited to ICE and caspase-
immunoprecipited with polyclonal antibodies against ICE or cas- 11. It is interesting to note that there are pairs of very
pase-11, and the coprecipitated caspase-11 or ICE was detected homologous caspases, e.g., caspase-3 and caspase-7,
by immunoblotting with anti-caspase-11 or anti-ICE monoclonal an-
caspase-8 and caspase-10. It is possible that physicaltibodies as indicated. The control antibody is anti-ICH-1 polyclonal
and functional interaction between different caspasesantibody.
may serve as a general mechanism of caspase acti-
vation.
complex with pro-ICE in cells. To determine if caspase- Although in vitro translated pro-ICE is stable in rabbit
11 directly interacts with ICE, we cotransfected cas- reticulocyte lysate even after extended incubation (Hu-
pase-11 and T7-tagged ICE into COS cells. Cell lysates gunin et al., 1996), recombinant p45 ICE has been shown
were immunoprecipitated with either anti-ICE or anti- to process itself during the purificationprocess (Ramage
caspase-11 polyclonal antibodies. The Western blots et al., 1995). Apparent autocatalysis of p45 ICE during
were probed with either anti-caspase-11 monoclonal purification and refolding is achieved at a p45 pro-ICE
antibody in the anti-ICE immune complex or anti-T7 concentration of 200 mg/ml or 4.4 mM, a concentration
antibody for detecting ICE in the anti-caspase-11 im- unlikely to be reached for in vivo conditions since the
mune complex (Figure 5A). Our result showed that cas- level of pro-ICE is low in all cells and even in monocytic
pase-11 is present in a comparable amount in the ICE cells stimulated to produce high levels of mature IL-1b,
immune complex and vice versa; and thus, caspase-11 the concentration of pro-ICE does not change apprecia-
and ICE can form a complex. bly. It is likely that the concentration of pro-ICE did not
To determine if endogenously expressed ICE and reach 4.4 mM intracellularly even when we overex-
caspase-11 physically interact, we immunoprecipitated pressed pro-Ice in casp-112/2 cells, since pro-ICE can-
L929 cell lysates, which express high levels of caspase- not be autoactivated in these cells. While the expression
11 and ICE, with either anti-ICE or anti-caspase-11 poly- levels of pro-ICE varies a little when cells are stimulated
clonal antibodiesand determinedwhether ICE ispresent to produce mature IL-1b efficiently by LPS, the expres-
in the caspase-11 immune complex and vice versa by sion of casp-11 is highly inducible (Wang et al., 1996).
Western blotting with their respective monoclonal anti- We have shown that when mice were stimulated by LPS,
bodies. As it shows in Figure 5B, we found that ICE was the expression of casp-11 can be induced up to 40-fold
present in the complex immunoprecipitated with an anti- (Wang et al., 1996). These results suggest that while
caspase-11 antibody and caspase-11 was present in the pro-ICE can autoprocess in vitro when in high concen-
tration, the activation of pro-ICE in vivo is likely to becomplex immunoprecipitated with an anti-ICE antibody.
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achieved through interaction with caspase-11. Thus, the possible that it is the murine analog of caspase-4 or
caspase-5, although it is not clear whether the expres-regulation of casp-11 gene expression is an important
control point for the ICE pathway in inflammatory re- sion of caspase-4 or caspase-5 can be induced by LPS.
Expression of caspase-4 in cells does not lead to pro-sponses.
In another series of experiments, Yamin et al. (1996) cessing and secretion of mature IL-1b, although acti-
vated caspase-4 can process pro-IL-1b in vitro veryhad shown that p45 pro-ICE in monocytic THP.1 cell
extract can be processed to p22 and p20 when incu- inefficiently compared to that of ICE (Faucheu et al.,
1995), suggesting that caspase-4 is not likely to directlybated in vitro, an activity which can be inhibited by ICE
inhibitors but not by other unrelated inhibitors. This data process pro-IL-1b in a physiological setting. Gu et al.
found that R314E mutation of caspase-4 can comple-is consistent with pro-ICE being processed by itself or
a closely related caspase. Interestingly, this cleavage ment the active center mutation C285S of ICE, and
R341E mutation of ICE can complement the active cen-activity is highly dilution sensitive: it can be detected if
cytosolic extract is prepared at 108 cell/ml (5 mg of ter mutation C258S in caspase-4 in processing of pro-
ICE, but it could not restore the ability of ICE to processprotein/ml or 0.5 mg of p45 pro-ICE/ml) but not when it
is diluted to 0.8 3 108 cell/ml. In contrast, similar dilution pro-IL-1b (Gu et al., 1995). This is consistent with our
hypothesis that murine caspase-11, or human cas-of p20/p10 ICE under these conditions results in no
significant loss of activity on pro-IL-1b substrate (Yamin pase-4, interacts and promotes pro-ICE processing but
is not directly involved in processing of pro-IL-1b. Inet al., 1996). This data suggests that, in THP.1 cell ex-
tract, processing of pro-ICE is not an intramolecular contrast to the low level of expression of casp-11 in
normal mouse tissues, however, the expression of casp-4event mediated by pro-ICE itself; it is achieved either
through intermolecular cleavage by two or more pro- is very high in normal healthy human tissues, which
argues against the hypothesis that caspase-4 is the hu-ICE molecules or by another caspase. Since the concen-
tration of p45 pro-ICE in THP.1 cell extract is at 0.5 mg/ man analog of caspase-11. On the other hand, the ex-
pression of caspase-5 is low in normal human tissuesml or 0.011 mM, which is 400-fold less than the concen-
tration of pro-ICE observed to undergo self-cleavage in (Munday et al., 1995). Whether caspase-4 or caspase-5
is the human analog of caspase-11 has to be resolvedvitro (Ramage et al., 1995), the activation of ICE in the
extract is more likely through another caspase than ICE by further experimentation.
Apoptotic phenotypes of casp-112/2 mutant miceitself.
Since we have shown physical interaction of pro-ICE (S. W. et al., unpublished observation) are very similar
to that of Ice2/2 mice (Kuida et al., 1995). Thymocytesand pro-caspase-11, thesimplest hypothesis is that they
form heterodimers. We examined this possibility by de- from casp-11-deficient mice are partially resistant to
apoptosis induced by anti-Fas antibody. casp-112/2 EFstermining if recombinant pro-caspase-11 can bind pro-
ICE in vitro and if in vitro translated pro-caspase-11 can are resistant to granzyme B-induced apoptosis. In addi-
tion, we found that apoptosis in thymus and spleenbind pro-ICE. Both experiments failed to show direct
heterodimeric interaction between pro-caspase-11 and induced by LPS is significantly reduced in casp-112/2
mice. Thus, apoptosis mediated by the ICE pathwaypro-ICE (S. W. and J. Y., unpublished data), although
the in vivo interaction of these two caspases are very may play an important role in immune suppression in
systemic inflammatory responses. Furthermore, the braineasily detectable. This result suggests that there may
be other components in the pro-ICE and pro-caspase- of casp-11 mutant mice is more resistant to ischemic
injury±induced apoptosis than that of wild-type mice,11 complex that are required for the functional and phys-
ical interaction. suggesting that the ICE pathway may be critical for
apoptosis under ischemic conditions. These findingsRecently, we demonstrated that a mutant ICE in which
the active site cysteine has been changed into a glycine underlined the important roles of ICE and caspase-11
in mediating apoptosis in pathological conditions andis a powerful inhibitor of apoptosis under pathologi-
cal conditions (Friedlander et al., 1997a, 1997b). Trans- the significance of understanding the mechanism of
regulation of the ICE pathway.genic mice expressing this mutant ICE are resistant to
apoptosis induced by middle cerebral artery occlusion,
a mouse model of stroke (Friedlander et al., 1997a). In Experimental Procedures
addition, expression of this mutant ICE in neurons of
mutant SOD mice, a mouse model of human aymo- Construction of the casp-11 Targeting Vector
A full-length casp-11 cDNA was used to screen a lambda dashtrophic lateral sclerosis, is able to slow the symptomatic
mouse genomic library of 129/Sv strain (Stratagene). To confirm theprogression of this disease and delay mortality (Fried-
identities of genomic clones, phage DNA was digested with SalI,lander et al., 1997b). We have indication that this mutant
and the genomic fragment was subcloned into pBluescript and ana-
ICE is a powerful inhibitor of caspase-11 but not ICE lyzed by Southern blots and DNA sequencing. One of the subclones,
(S. W. and J. Y., unpublished data), supporting a critical named BSMNO, which contains all the coding exons of casp-11,
role of physical interaction between ICE and caspase- was used to construct the targeting vector. A genomic 3.5 kb EcoRI
fragment, which contains the exon encoding the QACRG active site,11 in the activation of ICE pathway. Consistent with its
was subcloned into pBluescript (pJ453). An 8 kb EcoRI fragmentrole in regulating ischemic-induced apoptosis, casp-11
near 39 of the casp-11 gene was subcloned into pBluescript (pJ451).mutant mice are also resistant to middle cerebral artery
A polyadenylated neomycin resistance gene under the control of
occlusion (H. Hara et al., unpublished data). phosphoglycerokinase gene promoter (PGKneo) was inserted be-
Murine caspase-11 is most homologous to human tween a 2.2 kb EcoRI/AccI fragment of pJ453 and an 8 kb EcoRI
caspase-4 (TX/Ich-2/ICErelII) and caspase-5 (TY/ICErelIII) fragment of pJ451, and a thymidine kinase (tk) gene was ligated
with the 39 end of the 8 kb EcoRI fragment. The resulting targeting(Faucheu et al., 1995; Munday et al., 1995), and it is
Interaction of ICE and Caspase-11
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vector contains 2 kb of genomic DNA from the casp-11 gene before mated with C57BL/6J 3 DBA2 F1 females, and their progeny were
screened by Southern blot analysis. Southern blots of tail DNA di-the PGKneo insertion and 8 kb of genomic DNA downstream from
PGKneo and was named pJ476. A 1.5 kb genomic fragment of casp- gested with BamHI were probed with probe A as described in Figure
1. The wild-type allele is a 10 kb BamHI fragment and the mutant11 sequence, including the region coding for the active site QACRG,
was replaced with PGKneo in this targeting vector. To clone the 59 allele is an 8.7 kb BamHI fragment.
portion of the casp-11 genome, we screened the lFIX 129/Sv strain
genomic library (Stratagene) using an EcoRI/HindIII 0.3 kb fragment Septic Shock
of casp-11 cDNA (BSNO12), which contained exons 2 and 3 of casp- Mice were injected intraperitoneally with LPS from Escherichia coli
11 as a probe. We subcloned four different genomic phage DNA 0127:B7 (Sigma, St. Louis, MO) at a dose of 40 mg/kg body weight.
pieces into pBluescript (named BSNO3G, BSNO6G, BSNO11G, and The injected mice were monitored for signs of endotoxemia and
BSNO22G). From BSNO3G, we subcloned a 3 kb EcoRI fragment, lethality at least twice daily. The systemic release of cytokines after
which contained exon 2 and the introns surrounding exon 2. A 1.9 toxin challenge was determined by ELISA kits for murine IL-a and
kb fragment of exon 2 and the 59 intron was obtained by PCR using b (Genzyme, Cambridge, MA). Blood was taken 5 hr after LPS in-
the primer set of T3 and m29P2 (59-GGTCCACACTGAAGAATGTCTG jection.
GAGAAGCATTTCA) and was used as a probe for genomic Southern
blot. This probe detects a 10 kb and 8.7 kb BamHI fragment in Generation of ICE and Caspase-11 Antibodies
wild-type and mutant mice, respectively. We could detect the same and Western Blot Analysis
BamHI fragment by using an internal probe (a 3.5 kb EcoRI fragment The generation of monoclonal antibody against caspase-11 was
of pJ451, described as probe A in Figure 1). described previously (Wang et al., 1996). The same bacterial-
expressed fusion protein from pS8 was used for generating anti-
Determination of Intron/Exon Boundary caspase-11 polyclonal antibody by Research Genetic (Huntsville,
Various primers were used for sequencing the genomic clone AL). The polyclonal antibody was purified using 4% N-hydroxysuc-
(BSMNO) to determine the position of the intron/exon boundary. cinimidyl chloroformate±activated cross-linked beaded agarose
PCR was performed to determine the length of the intron. Primers (Sigma H8635) coupled to fusion protein according to manufactur-
used for this study were as follows: for exon 2, m29P2 (59-GGTCCAC er's protocol. The anti-ICE p20 monoclonal and polyclonal antibod-
ACTGAAGAATGTCTGGAGAAGCATTTCA); for exon 3, NO3 (59-CCA ies were generated in a similar way. Briefly, one pair of primers was
GAAGAATCATTGAACAC) and mNO15 (59-GAGAGTGTTCAATGA); used for amplifying the p20 fragment of ICE by PCR. The template
for exon 4, NOV1 (59-GCTGTAAGCTCCTCTTTCAC) and NOV2 (59- used was pJ348 and primers were 59-CGCGGATCCTGGCACATTTC
AAACATCTCTCACTGAGGTATGGGGCTAAATTT); for exon 5, NO1 CAGGAC-39 and 59-GCGGGATCCGTTCAGAAATCCTCTTC-39. The
(59-ACTCTCAGAACACCAGACATC) and NO2 (59-CCCACCTCTGCA p20 fragment was cloned into the BamHI site of pET15b (Novagen).
GGCCTGCAC); for exon 6, NOp10 (59-GCTGTCAAGCTGAGCC) ICE p20 fusion protein was purified in the same way as caspase-
and mNOp20R (59-TCAGCTTCCATATTCCATGG); for exon 7, M38 11 fusion protein, andthe generation of monoclonal antibodyagainst
(59-ATCACTTGTCCTACCGA); for exon 8, M50 (59-GGCAAGTATT the p20 of ICE were described previously (Wang et al., 1996). The
CATTCCC), NO4 (59-GATCAATGGTGGGCATCTGGGAA), and mNOR- polyclonal anti-ICE p20 fusion antibody was kindly generated by
Fusion (59-TTGCCAGGAAAGAGGTAGAAAT). Junlin Guan of Cornell University (Ithaca, NY).
For Western blot analysis, lysates were subjected to SDS-PAGE
on a 12% polyacrylamide gel, transferred onto Immobilon-P mem-Screening of ES Cells
J1-ES cells were maintained on feeder layers of mouse EF in the brane (Millipore, Bedford, MA), and incubated with primary antibod-
ies for 1 hr at room temperature. The filters were washed and incu-presence of 500 U/ml of leukemia inhibitory factor (GIBCO-BRL,
Grand Island, NY). ES cells were transfected with 15 mg linealized bated with horseradish peroxidase±linked second antibody for 45
min at room temperature (Amersham, Buckinghamshire, England).pJ476 by electroporation (400 V, 25 mF; Gene Pulser, Bio-Rad,
Hercules, CA). Thirty-six hours after transfection, G418 (200 mg/ml The signals wererevealed with the ECL kit (Amersham, Buckingham-
shire, England).of active form) was added to the medium and then 1 day later, 0.2
mM of FIAU (1-[2-deoxy, 2-fluoro-b-D-arabinofuranosyl]-5-iodoura-
cil; Bristol-Myers Squibb Pharmaceutical Research, Seattle, WA) Construction of casp-11 and Ice
was added to the medium. Resistant colonies were picked from day Expression Constructs
10±12 after transfection and expanded. DNA from each resistant Construction of pM10Z and pM26Z have been described previously
colony was isolated and subjected to Southern blot analysis to (Wang et al., 1996). The EGF expression construct (pEGFP-N1) was
identify clones that underwent homologous recombination. DNA from Clontech (San Diego, CA). The mutant casp-11 construct pS26
was extracted according to the method by Laird et al. (1991), di- was constructed by site-directed mutagenesis using full-length
gested with BamHI, and analyzed by Southern blot analysis probed casp-11 cDNA in pJ667 as a template. Two primers in which the
with a 3.5 kb EcoRI fragment of pJ453 (probe A in Figure 1A). active cystine residue is changed to glycine are: NO2GA, GTGCAGG
Correctly targeted casp-11 mutant alleles were screened among CCGGCAGAGGTGGG; and NO2GB, CCCACCTCTGCCGGCCTGCAC.
G418/FIAU resistant ES cell clones by Southern blot analysis using pS26 was made from two rounds of PCR using two pairs of primers.
an internal probe (probe A in Figure 1). The wild-type allele contains The first round of PCR was to generate the mutant DNA as two half
a 10 kb BamHI fragment and the mutant allele contains an 8.7 kb fragments. The 59 fragment from the N terminus to the mutation site
BamHI fragment because of an additional BamHI site in the neo was made using SY6 and NO2GB as primers. The 39 fragment from
cassette. Random integration of the targeting vector gives a 2.7 kb the mutated site to the C terminus was generated using NO2GA
BamHI fragment because the vector has an additional BamHI site and mNO/BH2 primers. In the second round of PCR, the mixture of
next to the insert. We successfully screened for homologous recom- the 59 fragment and 39 fragment was used as a template and SY6
binant ES clones using an internal probe because we hadtwo criteria and mNO/BH2 as primers. The product of the second PCR was a
to recognize a homologous recombination event. An external probe complete casp-11 cDNA with a mutation that changed the active
which encompasses a 2 kb genomic DNA fragment including exon cysteine to a glycine. The PCR product was inserted into the BamHI
2 was also used to confirm the homologous recombinants on addi- site of pcDNA3 and checked by PstI digestion to ensure that this
tional Southern blots (data not shown). All confirmed clones were site is removed after the mutation.
probed with the neo gene to ensure that there is only a single To construct the C-terminal Flag-tagged Casp-1, the SalI/BamHI
integration event (data not shown). The frequency of correctly tar- fragment isolated from BSm10Z (wt Casp-1) was inserted into the
geted clones is 16 out of 719 G418/FIAU doubly resistant colonies. SalI/BamHI site of pFlag-CMV-5b (Kodak). The resultant construct
was named pS34. To make C-terminal T7-tagged mutant ICE,
bbactM17-T7 (T7-Ice) was constructed by inserting a 169 bp BglIIProduction of Chimeric and Mutant Mice
C57BL/6J blastocytes were microinjected with 10±12 J1 cells from DNA fragment encoding a T7 epitope tag into the BamHI site of
bbactM17, in which the lacZ gene was deleted from bbactM17Za single targeted clone and implanted into pseudopregnant foster
females. Chimeric male progeny with .60% agouti coat color were (Miura et al., 1993). The T7 epitope tag fragment was obtained by
Cell
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PCR using pET-21a(1) (Novagen, Madison, WI) as a template and Fas and tumor necrosis factor-induced apoptosis. J. Biol. Chem.
271, 1621±1625.T71 and T72 as primers. The primer sequences are as follows: T71,
59-GAAGATCTGGCTAGCATGACTGGTGGACA-39; T72, 59-GAAGAT Duan, H., Orth, K., Chinnaiyan, A.M., Poirier, G.G., Froelich, C.J.,
CTGCTAGTTATTGCTCAGCGGTG-39. He, W., and Dixit, V. (1996b). ICE-LAP6, a novel member of the ICE/
Ced-3 gene family, is activated by the cytotoxic T cell protease
Generation of Embryonic Fibroblasts granzyme B. J. Biol. Chem. 271, 16720±16724.
To prepare casp-11 (1/1) and (2/2) EF cells, the casp-111/1 and Faucheu, C., Diu, A., Chan, A.W., Blanchet, A.-M., Miossec, C.,
casp-112/2 embryos at day 10±14 of gestation were isolated from Herve, F., Collard-Dutilleul, V., Gu, Y., Aldape, R.A., Lippke, J.A.,
casp-11 (1/1) and (2/2) females that had been crossed with homo- et al. (1995). A novel human protease similar to the interleukin-1b
zygous wild-type and homozygous casp-11 mutant males, respec- converting enzyme induces apoptosis in transfected cells. EMBO
tively. After removing the head and soft tissues, the carcasses were J. 14, 1914±1922.
washed in cold DMEM and minced in a small volume of trypsin/ Fernandes-Alnemri, T., Litwack, G., and Alnemri, E.S. (1994). CPP32,
EDTA. After incubation at 378C for 30 min, 10 ml of DMEM plus 10% a novel human apoptotic protein with homology to Caenorhabditis
FCS was mixed with the digested embryo tissues with vigorous elegans cell death protein Ced-3 and mammalian interleukin-1b-
pipetting to dissociate the tissues. After allowing the large pieces converting enzyme. J. Biol. Chem. 269, 30761±30764.
of tissue debris to settle down, the supernatant was transferred to
Fernandes-Alnemri, T., Litwack, G., and Alnemri, E.S. (1995a). Mch2,a clean dish. The EF cells were ready to be used after 2±3 passes.
a new member of the apoptotic Ced-3/Ice cysteine protease geneThe EF cells were further passed for two months and immortalized.
family. Cancer Res. 55, 2737±2742.
Fernandes-Alnemri, T., Takahashi, A., Armstrong, R., Krebs, J., Fritz,Transfection and Immunoprecipitation Analysis
L., Tomaselli, K., Wang, L., Yu, Z., Croce, C.M., Earnshaw, W.C., et293 and COS cells were used for transfection by CaCl2 method al. (1995b). Mch3, a novel human apoptotic cysteine protease highlyas described previously (Wang et al., 1996). To detect interaction
related to CPP32. Cancer Res. 55, 6045±6052.between caspase-11 and ICE, the full-length mutant casp-11 (pS26)
Friedlander, R.M., Gagliardini, V., Hara, H., MacDonald, G.,and T7-tagged mutant Ice (pM17-T7) were cotransfected into 293
Greenberg, A.H., Moskowitz, M.A., and Yuan, J. (1997a). Inhibitionor COS cells. Cells were washed once with PBS 48 hr after transfec-
of neuronal apoptosis in a transgenic mouse expressing a dominanttion and lysed in 1 ml of 1 3 IP lysis buffer containing 50 mM HEPES,
negative mutant of ICE. J. Exp. Med. 185, 933±940.150 mM NaCl, 1 mM EDTA, and 1% NP-40. The cell lysates were
Friedlander, R.M., Gagliardini, V., Wang, J., Brown, R.H., and Yuan,immunoprecipitated with polyclonal antibodies against caspase-11
J. (1997b). Protection in an ALS model by a dominant negative ICEor ICE. The immune complexes were resolved by SDS-PAGE and
inhibitor. Nature 388, 31.analyzed by immunoblotting to detect coprecipitated proteins by
monoclonal antibodies. Ghayur, T., Banerjee, S., Hugunie, M., Butler, D., Herzog, L., Carter,
A., Quintal, L., Sekut, L., Talanian, R., Paskind, M., et al. (1997).
Caspase-1 processes IFN-g-inducing factor and regulates LPS-Acknowledgments
induced IFN-g production. Nature 386, 619±623.
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